Report Detail
Diagnostic Imaging Devices Global Market – Forecast To 2025
- RnM2895590 |
- 19 July, 2019 |
- Global |
- 533 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Diagnostic imaging is a non-invasive method for identifying and monitoring diseases or injuries by generating the images of internal anatomic structures and organs of the body for diagnosis purpose. It is used for the diagnosis of the most life threatening diseases such as cancer and heart disease and has nearly eliminated the need for exploratory surgery. The use of diagnostic imaging devices is increasing significantly due to increased demand by patients and physicians as they provide precise information of disease condition which will help physicians to treat patients effectively and play an important role in the early diagnosis and prevention of disease. According to IQ4I analysis, the diagnostic imaging devices global market is expected to grow at a single digit CAGR to reach $46,481.7 million by 2025. The diagnostic imaging devices market is mainly segmented by products, technology, application, end-users and by geography.
The diagnostic imaging device by products is segmented into X-ray systems (portable and stationary), Computed Tomography (CT) Scanners (portable and stationary CT scanners), Magnetic Resonance Imaging (MRI) systems (open, closed MRI), Ultrasound systems (trolley/Cart based, Compact/portable based), Nuclear imaging systems (SPECT/PET), Mammography and other systems. In CT scanners segment stationary CT commanded the largest revenue in 2018 and expected to grow at a medium single digit CAGR from 2018 to 2025. Portable CT systems grow with a double digit CAGR from 2018 to 2025. In NI segment PET commanded the largest revenue in 2018 and expected to grow at a medium single digit CAGR from 2018 to 2025. SPECT systems grow with a high single digit CAGR from 2018 to 2025. In MRI segment closed sided MRI commanded the largest revenue in 2018 and expected to grow at a medium single digit CAGR from 2018 to 2025. Open sided MRI systems grow with a high single digit CAGR from 2018 to 2025. In ultrasound segment trolley/cart ultrasound systems based commanded the largest revenue in 2018 and expected to grow at a low single digit CAGR from 2018 to 2025. Compact/ portable ultrasound systems grow with a high single digit CAGR from 2018 to 2025. In X-ray systems stationary X-ray systems commanded the largest revenue in 2018 and expected to grow at a medium single digit CAGR from 2018 to 2025. Portable X-ray systems grow with a high single digit CAGR from 2018 to 2025.
The diagnostic imaging devices by technology is segmented into Computed Tomography Scanners (Low, Medium, High slice CT scanners), Nuclear Imaging Equipment (SPECT, PET), Magnetic Resonance Imaging Systems (Low, High, Very high field MRI), Ultrasound Scanners (2D, 3D, 4D, Doppler), X-ray Devices (Digital, Computed, Analog Radiography). In CT scanners medium size CT scanners segment commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR from 2018 to 2025. High slice CT systems grow with a high single digit CAGR from 2018 to 2025. In NI segment PET commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR from 2018 to 2025. SPECT systems grow with a high single digit CAGR from 2018 to 2025. In MRI segment High field MRI commanded the largest revenue in 2018 and expected to grow at a mid single digit CAGR from 2018 to 2025. Very high field MRI systems grow with a high single digit CAGR from 2018 to 2025. In ultrasound segment 2D ultrasound systems commanded the largest revenue in 2018 and expected to grow at a low single digit CAGR from 2018 to 2025. 3D and 4D systems grow with a high single digit CAGR from 2018 to 2025. In X-ray digital radiography segment commanded the largest revenue in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025.
Depending on the applications the diagnostic imaging market is segmented into cardiovascular, Cancer (Oncology), abdomen related disorders, neurology, orthopaedic related problems, pulmonology, gynaecology, dental and others. Among the application, cancer segment holds the highest share in 2018 and expected to grow at a high single digit CAGR from 2018 to 2025, due to Increase incidence of cancer disease, urge for the advanced imaging modalities.
Diagnostic imaging technologies global market by end users is segmented into hospitals, private diagnostic laboratories and research laboratories. Hospitals segment holds the highest share in 2018 and expected to grow at a single digit CAGR from 2018 to 2025, due to increasing in infrastructure of the hospital setup, government fund allocation, increase in the number of installed units of diagnostic imaging modalities, Improved patient safety and clinical outcomes and reducing diagnosis error drives the end users market. The private diagnostic centres segment is expected to grow with a high single digit CAGR from 2018 to 2025.
Diagnostic imaging global market is segmented into four major regions namely North America, Europe, Asia Pacific and Rest of World (ROW). North American region commanded the largest revenue in 2018 and expected to grow at a medium single digit CAGR from 2018 to 2025. Increasing growth in aging population with life threatening diseases and significant increase in diagnostic centers in U.S. has led the market growth in this region. However, Asia-Pacific is expected to grow at highest single digit CAGR from 2018 to 2025 owing to the rapidly increasing aging population.
Major players in the diagnostic imaging devices global market are Carestream Health, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (Germany), Philips N.V (Netherlands), Hitachi Medical Corporation (Japan), Hologic, Inc. (U.S.), Shimadzu Corporation (Japan), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan) and Shenzhen Mindray Bio-Medical Electronics (China).
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Rest of North America
• Europe
o Germany
o France
o U.K.
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o Rest of APAC
• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle East and Others
1 EXECUTIVE SUMMARY 30
2 INTRODUCTION 35
- 2.1 KEY TAKEAWAYS 35
- 2.2 SCOPE OF THE REPORT 36
- 2.3 REPORT DESCRIPTION 36
- 2.4 MARKETS COVERED 39
- 2.5 STAKEHOLDERS 41
- 2.6 RESEARCH METHODOLOGY 42
- 2.6.1 MARKET SIZE ESTIMATION 43
- 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 46
- 2.6.3 SECONDARY SOURCES 47
- 2.6.4 PRIMARY SOURCES 48
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 49
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 50
- 2.6.7 ASSUMPTIONS 51
3 MARKET ANALYSIS 53
- 3.1 INTRODUCTION 53
- 3.2 MARKET SEGMENTATION 54
- 3.3 FACTORS INFLUENCING MARKET 56
- 3.3.1 DRIVERS AND OPPORTUNITIES 57
- 3.3.1.1 Increasing prevalence of chronic diseases, rise in aging population 57
- 3.3.1.2 Increasing investments by government and private bodies to modernize diagnostic imaging facilities. 57
- 3.3.1.3 Technological advancements in diagnostic imaging modalities 59
- 3.3.1.4 Increasing demand for diagnostic modalities like mammography, MRI,
CT, X-ray and ultrasound 59
- 3.3.1.5 Growing awareness in early diagnosis and improving healthcare expenditure
- 3.3.1 DRIVERS AND OPPORTUNITIES 57
in emerging markets 60
- 3.3.2 RESTRAINTS AND THREATS 61
- 3.3.2.1 High cost of diagnostic imaging systems 61
- 3.3.2.2 Risk of radiation exposure limiting the use of some diagnostic imaging systems 62
- 3.3.2.3 Shortage of radiologists 62
- 3.3.2.4 Shortage in supply of technetium 99m for spect systems and helium for MRI systems 63
- 3.3.2.5 Alternative diagnostic technologies 64
- 3.3.2.6 Stringent regulatory requirements for product approval 64
- 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 66
- 3.4.1.1 ISO 9001: 2015 QUALITY MANAGEMENT SYSTEM 66
- 3.4.1.2 ISO 13485 MEDICAL DEVICES 66
- 3.4.2 U.S. 67
- 3.4.3 CANADA 68
- 3.4.4 EUROPE 69
- 3.4.5 JAPAN 70
- 3.4.6 CHINA 70
- 3.4.7 INDIA 71
- 3.5.1 INTRODUCTION 72
- 3.5.2 COMPUTED TOMOGRAPHY (CT) SCANNERS PATENT TREND 73
- 3.5.3 NUCLEAR IMAGING (SPECT AND PET) PATENT TREND 74
- 3.5.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS PATENT TREND 75
- 3.5.5 ULTRASOUND SCANNERS PATENT TREND 76
- 3.5.6 X-RAY DEVICES PATENT TREND 77
- 3.5.7 MAMMOGRAPHY PATENT TREND 78
- 3.6.1 INTRODUCTION 79
- 3.6.2 AFFINITY 70 ULTRASOUND SYSTEMS 79
- 3.6.3 SIGNA PRIEMIER 79
- 3.6.4 ACUSON SC2000 ULTRASOUND SYSTEM 79
- 3.6.5 GALAN 3T XGO EDITION MAGNETIC RESONANCE IMAGING (MRI)
SCANNER 80
- 3.6.6 XDIMENSUS 300 80
- 3.6.7 SYNGO.BREASTCARE 80
- 3.7.1 THREAT OF NEW ENTRANTS 82
- 3.7.2 THREAT OF SUBSTITUTES 82
- 3.7.3 BARGAINING POWER OF SUPPLIERS 83
- 3.7.4 BARGAINING POWER OF BUYERS 83
- 3.7.5 COMPETITIVE RIVALRY 84
- 3.9.1 DIAGNOSTIC IMAGING DEVICES GLOBAL MARKET SHARE ANALYSIS 89
- 3.9.2 MARKET SHARE ANALYSIS OF COMPUTED TOMOGRAPHY SCANNERS BY MAJOR PLAYERS 92
- 3.9.3 MARKET SHARE ANALYSIS OF NUCLEAR IMAGING (NI) EQUIPMENT BY MAJOR PLAYERS 94
- 3.9.4 MARKET SHARE ANALYSIS OF MRI SYSTEMS BY MAJOR PLAYERS 96
- 3.9.5 MARKET SHARE ANALYSIS OF ULTRASOUND SCANNERS BY MAJOR PLAYERS 99
- 3.9.6 MARKET SHARE ANALYSIS OF X-RAY DEVICES BY MAJOR PLAYERS 102
- 3.9.7 MARKET SHARE ANALYSIS OF MAMMOGRAPHY DEVICES BY MAJOR PLAYERS 104
- 3.11.1 CT SCANNERS NUMBER OF UNITS BY REGION 109
- 3.11.2 NUCLEAR IMAGING (NI) EQUIPMENT NUMBER OF UNITS BY REGION 111
- 3.11.3 MRI DEVICES NUMBER OF UNITS BY REGION 113
- 3.11.4 ULTRASOUND SCANNERS NUMBER OF UNITS BY REGION 115
- 3.11.5 X-RAY DEVICES NUMBER OF UNITS BY REGION 117
- 3.11.6 MAMMOGRAPHY DEVICES NUMBER OF UNITS BY REGION 119
- 3.12.1 INTRODUCTION 121
- 3.12.2 REIMBURSEMENT FOR CT 122
- 3.12.3 REIMBURSEMENT FOR NI 124
- 3.12.4 REIMBURSEMENT FOR MRI 125
- 3.12.5 REIMBURSEMENT FOR MAMMOGRAPHY 127
- 3.12.6 REIMBURSEMENT FOR ULTRASOUND 127
- 3.12.7 REIMBURSEMENT FOR X-RAY 128
- 3.13.1 REGURBISHED DIAGNOSTIC IMAGING DEVICES BY REGION 132
4 DIAGNOSTIC IMAGING DEVICES GLOBAL MARKET, BY PRODUCT 133
- 4.1 INTRODUCTION 133
- 4.2 COMPUTED TOMOGRAPHY (CT) SCANNERS 138
- 4.2.1 STATIONARY CT SCANNERS 144
- 4.2.2 PORTABLE CT SCANNERS 146
- 4.3 NUCLEAR IMAGING (NI) EQUIPMENT 148
- 4.3.1 SPECT 153
- 4.3.2 PET 155
- 4.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 157
- 4.4.1 OPEN MRI SYSTEM 164
- 4.4.2 CLOSED MRI SYSTEM 167
- 4.5 ULTRASOUND SCANNERS 169
- 4.5.1 TROLLEY/CART BASED 175
- 4.5.2 COMPACT/PORTABLE 178
- 4.6 X-RAY DEVICES 181
- 4.6.1 STATIONARY X-RAY DEVICES 187
- 4.6.2 PORTABLE X-RAY DEVICES 189
- 4.6.2.1 MOBILE X-RAY DEVICES 192
- 4.6.2.2 HANDHELD X-RAY DEVICES 194
- 4.7 MAMMOGRAPHY AND OTHERS 196
5 DIAGNOSTIC IMAGING DEVICES GLOBAL MARKET, BY TECHNOLOGY 200
- 5.1 INTRODUCTION 200
- 5.2 COMPUTED TOMOGRAPHY (CT) SCANNERS 203
- 5.2.1 LOW SLICE CT SCANNERS 208
- 5.2.2 MEDIUM SLICE CT SCANNERS 210
- 5.2.3 HIGH SLICE CT SCANNERS 212
- 5.3 NUCLEAR IMAGING (NI) EQUIPMENT 214
- 5.3.1 SPECT 219
- 5.3.2 PET 221
- 5.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 223
- 5.4.1 LOW AND MIDDLE FIELD MRI 228
- 5.4.2 HIGH FIELD MRI 230
- 5.4.3 VERY HIGH FIELD MRI 232
- 5.5 ULTRASOUND SCANNERS 234
- 5.5.1 2D ULTRASOUND SYSTEMS 239
- 5.5.2 3D AND 4D ULTRASOUND SYSTEMS 242
- 5.5.3 DOPPLER ULTRASONOGRAPHY 245
- 5.6 X-RAY DEVICES 248
- 5.6.1 DIGITAL RADIOGRAPHY 253
- 5.6.2 COMPUTED RADIOGRAPHY 256
- 5.6.3 ANALOG RADIOGRAPHY 258
- 5.7 MAMMOGRAPHY AND OTHERS 260
6 DIAGNOSTIC IMAGING DEVICES GLOBAL MARKET, BY APPLICATION 262
- 6.1 INTRODUCTION 262
- 6.2 CARDIOVASCULAR 266
- 6.3 CANCER 269
- 6.4 NEUROLOGY 272
- 6.5 ABDOMINAL 274
- 6.6 ORTHOPEDIC 277
- 6.7 PULMONARY 279
- 6.8 GYNECOLOGY 281
- 6.9 DENTAL 283
- 6.10 OTHER APPLICATIONS 285
7 DIAGNOSTIC IMAGING DEVICES GLOBAL MARKET, BY END-USERS 287
- 7.1 INTRODUCTION 287
- 7.2 HOSPITALS 290
- 7.3 PRIVATE DIAGNOSTIC LABORATORIES 292
- 7.4 RESEARCH LABORATORIES 294
8 REGIONAL ANALYSIS 296
- 8.1 INTRODUCTION 296
- 8.2 NORTH AMERICA 300
- 8.2.1 U.S. 321
- 8.2.2 REST OF NORTH AMERICA 326
- 8.3 EUROPE 330
- 8.3.1 GERMANY 351
- 8.3.2 FRANCE 355
- 8.3.3 U.K. 359
- 8.3.4 REST OF EUROPE 363
- 8.4 APAC 367
- 8.4.1 JAPAN 387
- 8.4.2 CHINA 392
- 8.4.3 AUSTRALIA 396
- 8.4.4 REST OF APAC 400
- 8.5 ROW 404
- 8.5.1 BRAZIL 424
- 8.5.2 REST OF LATAM 428
- 8.5.3 MIDDLE EAST AND OTHERS 432
9 COMPETITIVE LANDSCAPE 436
- 9.1 INTRODUCTION 436
- 9.2 NEW PRODUCT LAUNCH 437
- 9.3 APPROVALS 443
- 9.4 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS 446
10 MAJOR COMPANIES 449
- 10.1 CANON INC. (CANON MEDICAL SYSTEMS CORPORATION) 449
- 10.1.1 OVERVIEW 449
- 10.1.2 FINANCIALS 450
- 10.1.3 PRODUCT PORTFOLIO 453
- 10.1.4 KEY DEVELOPMENTS 454
- 10.1.5 BUSINESS STRATEGY 457
- 10.1.6 SWOT ANALYSIS 458
- 10.2 CARESTREAM HEALTH, INC. 459
- 10.2.1 OVERVIEW 459
- 10.2.2 FINANCIALS 459
- 10.2.3 PRODUCT PORFOLIO 460
- 10.2.4 KEY DEVELOPMENTS 461
- 10.2.5 BUSINESS STRATEGY 462
- 10.2.6 SWOT ANALYSIS 463
- 10.3 FUJIFILM HOLDINGS CORPORATION 464
- 10.3.1 OVERVIEW 464
- 10.3.2 FINANCIALS 465
- 10.3.3 PRODUCT PORTFOLIO 468
- 10.3.4 KEY DEVELOPMENTS 469
- 10.3.5 BUSINESS SRATEGY 470
- 10.3.6 SWOT ANALYSIS 471
- 10.4 GE HEALTHCARE (GENERAL ELECTRIC COMPANY) 472
- 10.4.1 OVERVIEW 472
- 10.4.2 FINANCIALS 473
- 10.4.3 PRODUCT PORTFOLIO 477
- 10.4.4 KEY DEVELOPMENTS 479
- 10.4.5 BUSINESS STRATEGY 480
- 10.4.6 SWOT ANALYSIS 481
- 10.5 HITACHI, LTD. (HITACHI MEDICAL) 482
- 10.5.1 OVERVIEW 482
- 10.5.2 FINANCIALS 483
- 10.5.3 PRODUCT PORTFOLIO 486
- 10.5.4 KEY DEVELOPMENTS 487
- 10.5.5 BUSINESS STRATEGY 489
- 10.5.6 SWOT ANALYSIS 490
- 10.6 HOLOGIC, INC. 491
- 10.6.1 OVERVIEW 491
- 10.6.2 FINANCIALS 492
- 10.6.3 PRODUCT PORTFOLIO 495
- 10.6.4 KEY DEVELOPMENTS 495
- 10.6.5 BUSINESS STRATEGY 496
- 10.6.6 SWOT ANALYSIS 497
- 10.7 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 498
- 10.7.1 OVERVIEW 498
- 10.7.2 FINANCIALS 498
- 10.7.3 PRODUCT PORTFOLIO 499
- 10.7.4 KEY DEVELOPMENTS 500
- 10.7.5 BUSINESS STRATEGY 500
- 10.7.6 SWOT ANALYSIS 501
- 10.8 KONINLIKJKE PHILIPS N.V 502
- 10.8.1 OVERVIEW 502
- 10.8.2 FINANCIALS 503
- 10.8.3 PRODUCT PORTFOLIO 506
- 10.8.4 KEY DEVELOPMENTS 508
- 10.8.5 BUSINESS STRATEGY 510
- 10.8.6 SWOT ANALYSIS 511
- 10.9 SHIMADZU 512
- 10.9.1 OVERVIEW 512
- 10.9.2 FINANCIALS 513
- 10.9.3 PRODUCT PORTFOLIO 516
- 10.9.4 KEY DEVELOPMENTS 518
- 10.9.5 BUSINESS STRATEGY 519
- 10.9.6 SWOT ANALYSIS 520
- 10.10 SIEMENS AG (SIEMENS HEALTHCARE) 521
- 10.10.1 OVERVIEW 521
- 10.10.2 FINANCIALS 522
- 10.10.3 PRODUCT PORTFOLIO 525
- 10.10.4 KEY DEVELOPMENTS 529
- 10.10.5 BUSINESS STRATEGY 531
Summary:
Get latest Market Research Reports on Diagnostic Imaging Devices – Forecast To 2025. Industry analysis & Market Report on Diagnostic Imaging Devices – Forecast To 2025 is a syndicated market report, published as Diagnostic Imaging Devices Global Market – Forecast To 2025. It is complete Research Study and Industry Analysis of Diagnostic Imaging Devices – Forecast To 2025 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
